Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$13.8M
Company Overview
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series A round in May 2026.
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. is a biotechnology company that researches and develops next-generation universal cell therapy products, including therapeutic cell vaccines and in vivo CAR-T platforms for oncology treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Comparables
Compare Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 81% | |
| Shenzhen MagicRNA Biotechnology Co., Ltd. | 80% | |
| Umoja Biopharma | 78% |
For institutional investors. Book with your work email.
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Seed | Oct 17, 2023 |
For institutional investors. Book with your work email.
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| Legend Capital | Series A, Seed |
| Shengjing Jiacheng | Series A |
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. a public or private company?
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. is a private company.
What is the current stock price of Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.?
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. worth (valuation)?
Valuation information for Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. is not publicly available.
Can I buy Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. stock?
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s last funding round?
Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s most recent funding round was Series A on May 27, 2026.
Who are the main investors in Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.?
Key investors in Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. include YuanBio Venture Capital, Legend Capital.
Will Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd..
How can I track Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s shares on secondary markets.